Written by: marc

Tagworks will present at BioEquity 2024

Marc Robillard will present Tagworks at the 24th BioEquity Europe on May 14 at 11:30 in San Sebastián, Spain.
April 23, 2024

Tagworks Strenthens Management Team

We are pleased to announce the recent appointments of Maria V. Cincotta as our VP of Clinical Operations & Program Management and Tu-Anh T. Bui as our VP of CMC & Technical Operations.
February 27, 2024

Meet Tagworks at the 17th Annual European Life Sciences CEO Forum 

The 17th Annual European Life Sciences CEO Forum will take place on the 28th - 29th February 2024 back at the Hilton Zurich Airport Hotel. The event will be part of the Sachs Spring Life Sciences Week.
February 20, 2024

Meet Tagworks in San Francisco during JPM’24

The 42nd Annual Healthcare Conference will take place on January 8-11, 2024 in San Francisco, CA.
December 12, 2023

Meet Tagworks at the World ADC meeting in San Diego

The World ADC San Diego Antibody-drug Conjugate Conference will take place from October 16-19, 2023.
October 9, 2023

Click wins the Nobel !

Tagworks congratulates Carolyn Bertozzi, Morten Meldal and Barry Sharpless with winning the Nobel Prize in Chemistry 2022 for the development of click chemistry and bioorthogonal chemistry ! Their discoveries made a massive impact on many areas of science and form the foundation of Tagworks' Click-to-Release approach. https://www.nobelprize.org/prizes/chemistry/2022/summary/  
October 5, 2022

Tagworks announces completion of investment round

Tagworks announces the completion of an investment round led by Meneldor (The Netherlands), Oost NL (The Netherlands), and a syndicate of high net-worth private investors. The proceeds of the financing will be used for the clinical development of Tagworks' lead program.    
November 27, 2021

Key Patent Covering Click-to-Release Granted in the United States

A key patent that encompasses the therapeutic application scope of the Click-to-Release platform has been granted in the US (US 10,967,069 B2), further strengthening Tagworks’ IP portfolio. The patent titled “BIO-ORTHOGONAL DRUG ACTIVATION”, covers the invention of the pyridazine elimination reaction that underlies the Click-to-Release approach. The patent protects a …
April 6, 2021

Tagworks reports new Click-to-Release reaction

Tagworks reports the development of a new and highly reactive Click-to-Release reaction in the Journal of the American Chemical Society. Great collaboration between Tagworks and SyMO-Chem, Syncom, TU/e , Avipep and Levena. https://pubs.acs.org/doi/abs/10.1021/jacs.0c00531
May 27, 2020

Tagworks wins 2019 World ADC Award for Best Publication

Tagworks is pleased to announce that on the 10th of October, it won the World ADC Award for Best Publication during the 10th World ADC Summit 2019 in San Diego. The World ADC Awards exist to commend excellence across nine categories within antibody-drug conjugate research and development. Tagworks applies its Click-to-Release platform …
November 1, 2019

Curious about what we do? Get in touch!

Logo-diap

About    Our Technology   Pipeline    Join us    News    Contact

Contact
T +31 85 800 8550
info@tagworkspharma.com

Address
Tagworks Pharmaceuticals BV
Toernooiveld 1
6525 ED  Nijmegen
The Netherlands

Stay updated

© Tagworks Pharmaceuticals, 2024 | Terms of use | Design by Ape to Zebra